Heron Therapeutics | HRTX - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
ALKERMES USD 1.81B 57.02M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amarin USD 443.62M 5.8M 2026-06
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Anika Therapeutics USD 137.28M 3.38M 2026-06
Arrowhead Research USD 465.53M 148.45M 2026-06
Eisai JPY 906.56B 7.57B 2026-06
Emergent BioSolutions USD 649.3M 47.9M 2023-12
GlaxoSmithKline GBP 17.64B 223M 2026-06
Heron Therapeutics USD 6.91M 2.23M 2026-06
Insmed USD 757.49M 52.64M 2026-06
Ligand Pharmaceuticals USD 967.52M 29.81M 2026-06
Merck USD 41.93B 3.94B 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 671.98M 18.08M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Veracyte USD 1.39B 44M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06